Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Profits lag behind sales growth at Disetronic

This article was originally published in Clinica

Executive Summary

The net income of the Swiss drug delivery company, Disetronic went up by 10% to reach SwFr22 million ($15 million), in the year ended March 31, while total sales increased by 29% to SwFr132 million. The company, of Burgdorf, said that the disproportionately small growth in net income, compared with sales growth, was due to a more conservative investment policy and the currency movements.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts